Literature DB >> 8093220

Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.

R J Owens1, J K Rose.   

Abstract

Incorporation of human immunodeficiency virus type 1 (HIV-1) envelope proteins into vesicular stomatitis virus (VSV) particles was studied in a system that allows expressed envelope proteins to rescue phenotypically a temperature-sensitive mutant of VSV (tsO45). This mutant exhibits defective transport of its own envelope glycoprotein (G) and can be rescued by simultaneous expression of wild-type G protein from cDNA. We report here that a hybrid HIV-1-VSV protein containing the extracellular and transmembrane domains of the HIV-1 envelope protein fused to the cytoplasmic domain of VSV G protein was able to rescue the tsO45 mutant lacking the G protein, while the wild-type HIV-1 envelope protein was not. The VSV(HIV) pseudotypes obtained infected only CD4+ cells and were neutralized specifically by anti-HIV-1 sera. Our results indicate that the cytoplasmic tail of the VSV glycoprotein contains an independent signal capable of directing a foreign protein into VSV particles. The VSV(HIV) pseudotypes generated here were prepared in the absence of HIV-1 and should be useful for identifying molecules that block HIV-1 entry.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093220      PMCID: PMC237371     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses.

Authors:  R A Weiss; P L Bennett
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

2.  Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells.

Authors:  R J Owens; R W Compans
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature.

Authors:  T J Schnitzer; C Dickson; R A Weiss
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  D H Gabuzda; A Lever; E Terwilliger; J Sodroski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

6.  Complementation and phenotypic stabilization of vesicular stomatitis virus temperature-sensitive and thermolabile mutants by avian myeloblastosis virus.

Authors:  J Závada; E Závodská
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

7.  Subunit composition of the membrane glycoprotein complex of Semliki Forest virus.

Authors:  A Ziemiecki; H Garofff
Journal:  J Mol Biol       Date:  1978-07-05       Impact factor: 5.469

8.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant.

Authors:  M A Whitt; L Chong; J K Rose
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus.

Authors:  O N Witte; D Baltimore
Journal:  Cell       Date:  1977-07       Impact factor: 41.582

View more
  49 in total

1.  Role of rubella virus glycoprotein domains in assembly of virus-like particles.

Authors:  M Garbutt; L M Law; H Chan; T C Hobman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

4.  Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destruction.

Authors:  Rajeev Gautam; Arun Iyer; Meredith Hunter; Arpita Das; Tessa Williams; Jason Dufour; Cristian Apetrei; K Gus Kousoulas; Preston A Marx
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 5.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Functional role of the cytoplasmic tail domain of the major envelope fusion protein of group II baculoviruses.

Authors:  Gang Long; Xiaoyu Pan; Marcel Westenberg; Just M Vlak
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

8.  Recombinant vesicular stomatitis viruses from DNA.

Authors:  N D Lawson; E A Stillman; M A Whitt; J K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.

Authors:  Arnab Basu; Aster Beyene; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.